APA

Chen Q., Ning Z., Wang L., Ying H., Dong S., Zhang C., Shen X., Guo Y., Chen H., Zhu X., Shen Y., Shi W., Hua Y., Wang K., Lin J., Xu L., Chen L., Feng L., Zhang X., Xie J., Sun B., Sun Y., Gu W., Kang M., Tang Z., Chen Z., Chen Z., Liu L., Yu J., Li Z. & Meng Z. (20180221). Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study. : Oncotarget.

Chicago

Chen Qiwen, Ning Zhouyu, Wang Lei, Ying Haifeng, Dong Shu, Zhang Chenyue, Shen Xiaoheng, Guo Yuanbiao, Chen Hao, Zhu Xiaoyan, Shen Yehua, Shi Weidong, Hua Yongqiang, Wang Kun, Lin Junhua, Xu Litao, Chen Lianyu, Feng Lanyun, Zhang Xiumei, Xie Jing, Sun Bo, Sun Yaqin, Gu Wenchao, Kang Mei, Tang Zheng, Chen Zhujun, Chen Zhen, Liu Luming, Yu Jinming, Li Zhaoshen and Meng Zhiqiang. 20180221. Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study. : Oncotarget.

Harvard

Chen Q., Ning Z., Wang L., Ying H., Dong S., Zhang C., Shen X., Guo Y., Chen H., Zhu X., Shen Y., Shi W., Hua Y., Wang K., Lin J., Xu L., Chen L., Feng L., Zhang X., Xie J., Sun B., Sun Y., Gu W., Kang M., Tang Z., Chen Z., Chen Z., Liu L., Yu J., Li Z. and Meng Z. (20180221). Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study. : Oncotarget.

MLA

Chen Qiwen, Ning Zhouyu, Wang Lei, Ying Haifeng, Dong Shu, Zhang Chenyue, Shen Xiaoheng, Guo Yuanbiao, Chen Hao, Zhu Xiaoyan, Shen Yehua, Shi Weidong, Hua Yongqiang, Wang Kun, Lin Junhua, Xu Litao, Chen Lianyu, Feng Lanyun, Zhang Xiumei, Xie Jing, Sun Bo, Sun Yaqin, Gu Wenchao, Kang Mei, Tang Zheng, Chen Zhujun, Chen Zhen, Liu Luming, Yu Jinming, Li Zhaoshen and Meng Zhiqiang. Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study. : Oncotarget. 20180221.